BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 21, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

July 8, 2020

View Archived Issues
Illustration of patient undergoing treatment with Reflexion X1

Reflexion, Telix Pharmaceuticals to collaborate to treat high-risk cancers

Reflexion Medical Inc. appears to be on a roll. A little more than a month after unveiling a tie up with Merck & Co. Inc., it now has reported a collaboration with Telix Pharmaceuticals Ltd., a radiopharmaceutical company developing molecularly targeted radiation products. Read More
Patient video chatting with doctor on mobile phone

Doctor On Demand raises $75M in series D

Virtual care provider Doctor On Demand has scooped up $75 million in a series D round led by General Atlantic, with participation from existing investors. The funds are earmarked to fuel the company’s growth and expand access to comprehensive telehealth services across the U.S. Combined with earlier financings, the San Francisco-based company has raised nearly $240 million to date. Read More
Clinical trial patient tested

U.S. FDA urges test developers to amend EUAs for pooled sample testing

The U.S. FDA’s priorities for testing for the SARS-CoV-2 virus have shifted as circumstances have changed, and the agency is putting more emphasis into testing of pooled samples. Toby Lowe, the associate director of the Office of In Vitro Diagnostics and Radiological Health (OIR), said on the July 8 diagnostic town hall that the agency wants to encourage test developers to work on their existing EUAs for pooled sampling. Read More
US-budget-spending-money.png

Partisan votes on U.S. federal agency appropriations foreshadow showdown between House, Senate

Two subcommittees of the U.S. House Appropriations Committee have moved their respective appropriations proposals for the FDA and the NIH, restarting a process that has worked smoothly over the past couple of years. Still, Republicans in both committees objected to the use of emergency funding mechanisms in lieu of more routine appropriations. Read More
Product image

Nonin nabs FDA nod for wireless handheld for first responders to monitor oxygen indicators

Plymouth, Minn.-based Nonin Medical Inc. gained a U.S. FDA 510(k) clearance for its Co-Pilot wireless hand-held multiparameter system (H500). The system is expected to be used by first responders to evaluate various oxygenation and respiratory-related parameters in patients after incidents such as cardiac arrest, traumatic injury, carbon monoxide or smoke inhalation. Read More

Appointments and advancements for July 8, 2020

New hires and promotions in the med-tech industry, including: Dynatronics, Eko, Huami, Koru Medical Systems, Notable. Read More

Financings for July 8, 2020

Med-tech firms raising money in public or private financings, including: Centogene, Immucor, Lumithera. Read More

In the clinic for July 8, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sime. Read More

Other news to note for July 8, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, American Medical Depot, Attomarker, Becton Dickinson, Bia Separations, Biolase, Chugai Pharmaceutical, Cleveland Clinic Florida, Daxor, Decision Diagnostics, Eos Imaging, Guardant Health, Genex India Bioscience, Global Swift Sensor Distribution, Incode, It Technologies, Janssen Biotech, Ocutrx, Paragon Genomics, Philips, Pulmatrix, Qualcomm, Roche, Run:AI, Sensory Cloud, Smiths Detection, Sonde Health, Thermo Fisher Scientific, Ultraviolet Devices. Read More

Regulatory actions for July 8, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Balt, Nonin Medical, Saladax Biomedical, Urocam. Read More

Regulatory front for July 8, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Luminex, Modern Allergy Management, WHO. Read More

BioWorld MedTech’s Orthopedics Extra for July 8, 2020

Keeping you up to date on recent developments in orthopedics, including: Buzzing to rebuild broken bone; Tiny mineral particles are better vehicles for promising gene therapy; New trial results question standard treatment plan for rheumatoid arthritis. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 20, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Microscopic view of the ebola virus

    WHO declares Ebola outbreak a public health emergency of international concern

    BioWorld
    The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing